Top Markets
#1 Status Status +19.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +14.26%
#4 Ontology Gas Ontology Gas +12.27%
#5 DMT-NAT DMT-NAT +8.99%
#6 Nillion Nillion +7.04%
#7 Provenance Blockchain Provenance Blockchain +7.02%
#8 Janction Janction +6.49%
#9 Cap Cap +6.34%
#10 Bedrock Bedrock +5.75%
Coin of the day
Status Status
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Rang în acțiuni #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Preț acțiune
$0.1502
Ultima sincronizare: 2024-11-04
Capitalizare de piață
$6.43M
Schimbare (1 zi)
-5.45%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Renalytix Plc (RNLX)

Categorie

Healthcare
Câștiguri pentru Renalytix Plc (RNLX)
Câștiguri în Sep 2024 TTM: $-28.67M
Conform celor mai recente rapoarte financiare ale Renalytix Plc, câștigurile actuale ale companiei sunt $-28.67M. În anul 2023, compania a înregistrat un câștig de $-46.22M, o scădere comparativ cu câștigului din 2022, care a fost de $-45.25M. Câștigurile afișate pe această pagină sunt cele înainte de dobânzi și impozite, cunoscute și ca EBIT.
Istoricul câștigurilor pentru Renalytix Plc din 2018 până în 2026
Câștiguri la sfârșitul fiecărui an
An Câștiguri Schimbă
2026 (TTM) $-28.67M -14.29%
2024 $-33.45M -27.63%
2023 $-46.22M 2.14%
2022 $-45.25M 26.44%
2021 $-35.79M 237.30%
2020 $-10.61M 62.78%
2019 $-6.52M 1,459.33%
2018 $-418.00K 0.00%
Câștiguri pentru companii similare sau concurente
Companie Câștiguri Diferență de câștiguri Țara
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
$2.04B -7,225.67%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
$222.34M -875.49%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
$295.53M -1,130.77%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
$-259.89M 806.47%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
- -
US